Cargando…

Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis

BACKGROUND: This study was designed to explore the therapeutic effect and mechanism of action of Qishen Yiqi dropping pills (QYDP) in chronic heart failure (CHF) via a long non-coding RNA (lncRNA)-microRNA (miRNA)-messenger RNA (mRNA) axis. Here, the mechanism of action of the lncRNA terminal differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lei, Pan, Lihua, Zhang, Yuansheng, Chen, Yuewu, Su, Yangshen, Luo, Ying, Wu, Zengfan, Zheng, Wanling, Cai, Shikang, Liu, Xianxia, Wu, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745534/ https://www.ncbi.nlm.nih.gov/pubmed/36524095 http://dx.doi.org/10.21037/jtd-22-1322

Ejemplares similares

Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
por: Luo, Ying, et al.
Publicado: (2022)

Antiplatelet Effects of Qishen Yiqi Dropping Pill in Platelets Aggregation in Hyperlipidemic Rabbits
por: Wang, Yi, et al.
Publicado: (2012)

Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia
por: JianXin, Chen, et al.
Publicado: (2016)

Protective effect of Qishen Yiqi dropping pills on the myocardium of rats with chronic heart failure
por: Lu, Yinghong, et al.
Publicado: (2019)

Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-Induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis
por: Wang, Lijiang, et al.
Publicado: (2019)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
por: Wang, Hao, et al.
Publicado: (2020)

Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose‐induced injury in cardiomyocytes
por: Zhang, Shouyan, et al.
Publicado: (2019)

Qishen Yiqi dripping pills for ischemic heart failure: A protocol for a prospective cohort study
por: Zhao, Zhiqiang, et al.
Publicado: (2018)

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial
por: Mao, Jingyuan, et al.
Publicado: (2020)

The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses
por: Chen, Wensheng, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Lisheng, et al.
Publicado: (2021)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis
por: Zheng, Shichao, et al.
Publicado: (2015)

Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
por: Li, Shaohua, et al.
Publicado: (2022)

Efficacy and safety of Qishen Yiqi dripping pills as a complementary treatment for Heart Failure: A protocol of updated systematic review and meta-analysis
por: Guan, Hui, et al.
Publicado: (2021)

Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
por: Zhang, Qian, et al.
Publicado: (2021)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
por: Li, Meng, et al.
Publicado: (2022)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017)

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention
por: Yu, Linghua, et al.
Publicado: (2021)

Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats
por: Wang, Hui, et al.
Publicado: (2021)

Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction
por: Wang, Yangyun, et al.
Publicado: (2019)

Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment
por: Li, Zheng, et al.
Publicado: (2021)

RORA and Autism in The Isfahan Population: Is There An Epigenetic Relationship
por: Salehi, Mansoor, et al.
Publicado: (2017)

Rora Regulates Neutrophil Migration and Activation in Zebrafish
por: Hsu, Alan Y., et al.
Publicado: (2022)

Role of simvastatin and RORa activity in the macrophage apoptotic pathway
por: Çoban, Neslihan, et al.
Publicado: (2017)

TINCR: An lncRNA with dual functions in the carcinogenesis process
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020)

Efficacy of Yougui pill combined with Buzhong Yiqi decoction in alleviating the sexual dysfunction in female rats through modulation of the gut microbiota
por: Wang, Yangyun, et al.
Publicado: (2021)

Mapping Rora expression in resting and activated CD4+ T cells
por: Haim-Vilmovsky, Liora, et al.
Publicado: (2021)

METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA
por: Meng, Liping, et al.
Publicado: (2022)

Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson’s disease
por: Yu, Dingyi, et al.
Publicado: (2021)

TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma
por: Tian, Feng, et al.
Publicado: (2017)

Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism
por: Li, Chun, et al.
Publicado: (2016)

Qishen Granule Improved Cardiac Remodeling via Balancing M1 and M2 Macrophages
por: Lu, Wenji, et al.
Publicado: (2019)

RORA alleviates LPS-induced apoptosis of renal epithelial cells by promoting PGC-1α transcription
por: Li, Dayong, et al.
Publicado: (2022)

A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure
por: Liu, Junjie, et al.
Publicado: (2019)

E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis
por: Xu, Tong-Peng, et al.
Publicado: (2017)

Investigation of Associations between NR1D1, RORA and RORB Genes and Bipolar Disorder
por: Lai, Yin-Chieh, et al.
Publicado: (2015)

Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia in vivo and in vitro
por: Qi, Jianyong, et al.
Publicado: (2017)

LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer
por: Wang, Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fl581j3nrtd7cd42v07i642t6i